Premier Biomedical Inc Stock Price - BIEID

Best deals to access real time data!
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Premier Biomedical Inc BIEID Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0 +0% 0.3285 0.3285 0.27 0.31925 0.3285 13:39:47
Bid Price Ask Price Spread Spread % News
0.27 0.3285 0.0585 17.81% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
6 2,342 $ 0.3137 $ 734.701794 3.99M 0.0014 - 0.50
Last Trade Time Type Quantity Stock Price Currency
14:00:08 40 $0.28 USD

Premier Biomedical Inc Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 981.96k 2.99M $ -3.76M - -0.26 2.76M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Premier Biomedical Inc News

Latest BIEID Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BIEID Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.3430.3460.210.31931k10k7k-0.0145-4.23%
1 Month0.0020.50.00160.00631k5M920k0.326516,325.00%
3 Months0.00230.50.00140.00231k20M4M0.326214,182.61%
6 Months0.00370.50.00140.00371k66M7M0.32488,778.38%
1 Year0.010750.50.00140.00411k66M6M0.317752,955.81%
3 Years0.080.50.00140.00991k66M5M0.2485310.63%
5 Years0.350.510.00140.01007566M5M-0.0215-6.14%

Premier Biomedical Inc Description

We are a research-based company that intends to discover and develop medical treatments for humans. We have a three-fold corporate focus: (i) develop and market pain management products, (ii) develop our proprietary Sequential-Dialysis Technique to target cancer, Alzheimer's disease, ALS, blood sepsis, leukemia and other life-threatening cancers, and (iii) develop our proprietary drug candidate Feldetrex(TM), a potential treatment for Multiple Sclerosis, Fibromyalgia, Neuropathic Pain and Traumatic Brain Injury. Our focus recently has been on our pain management products. We are engaged in several discussions to find a suitable partner to work with us on the anti-cancer drug development.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.